Let's connect

Want to discuss your project or have any questions?

Functional and mechanistic assays

Mode-of-action cell-based assays 

Mode-of-action assays are crucial for understanding disease mechanisms. Unlock the power of precision research with our comprehensive toolbox of cell-based functional and mechanistic assays, including image-based assays, 2D and 3D culture systems, and indication-specific mode-of-action assays, all designed to deliver tailored solutions for disease-relevant insights. 

Robotics transfers microtiter plater into multimode plate reader.

Advanced cell-based assays for mechanistic and functional characterisation of your assets 

Mechanistic and functional assays are essential tools in understanding the underlying biology of diseases and evaluating the efficacy of potential treatments. Our team leverages an extensive range of cellular assay technologies to support our clients at every stage of their drug discovery journey. We can assist with the selection, optimisation and validation of the most promising chemical, biological or cellular leads, to help ensure that you achieve reliable and actionable results. Our expertise and state-of-the-art facilities enable us to deliver tailored solutions that drive your projects forward with precision and confidence.

  • Cell proliferation assays: MTT, BrdU incorporation, colony formation, image-based assays (Incucyte, Celligo, HCA, CTG)
  • Cytotoxicity assays: LDH, caspase-3/7, annexin V/PI staining
  • Migration and invasion assays: wound healing, transwell migration, matrigel invasion
  • Signal transduction assays: luciferase or fluorescence-based reporter assays, calcium mobilisation assay
  • Apoptosis and cell death assays: TUNEL, mitochondrial membrane potential assay, DNA damage, HCA
  • Cell differentiation assays: FACS, alkaline phosphatase staining
  • Endocytosis and exocytosis assays: xCelligence-based impedance, fluorescence microscopy, FACS-based cell sorting
  • Protein-protein interaction assays: co-immunoprecipitation, FRET, BRET
  • Gene expression assays: qPCR, RNA sequencing
  • Protein expression: Western blot, Simple Western, in-cell Western, HCA, cell painting, cell morphology, protein localisation, G-Liza, Alpha-Liza, HTRF, IHF, FACS, spatial profiling, global proteomics
  • Chromatin immunoprecipitation (ChIP)
  • Mass spectrometry-based proteomics
  • Proteasomal degradation/activity assays
  • Sequencing: preclinical and clinical material, RNA/DNA sequencing, ChIP-seq, ATAC-seq, single-cell RNA-Seq, Perturb-seq
  • Metabolic assays: Seahorse XF Analyzer, glucose uptake assay.

IFNgamma-pretreated cancer cells form spheroids on low-attachment plates; PBMCs added to assess spheroid viability via Incucyte

Cancer cells pretreated with IFNgamma are plated on low-attachment plates for spheroid formation. Activated or naïve PBMCs are added to co-culture. Effects of PBMCs on viability of cancer spheroids are detected by image-based readout using an Incucyte. 

Related topics & resources

Assessing kidney organoid morphology using high-throughput high-content imaging

Poster: cell line generation

Explore Nuvisan’s capabilities of cell line engineering for disease modelling and drug screening.

download
 Protein degradation machineries in eukaryotic cells 3d rendering

Flyer: degrader platform

Our experts provide a comprehensive protein degradation platform encompassing a full range of PROTAC® and molecular glue drug discovery services.

download
Female laboratory scientist holding a flow chamber

Flyer: NGS solutions  

Our NGS service workflow can be customised to address your specific needs.

download